These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30747273)

  • 1. Autologous mesenchymal stem cell implantation, hydroxyapatite, bone morphogenetic protein-2, and internal fixation for treating critical-sized defects: a translational study.
    Dilogo IH; Phedy P; Kholinne E; Djaja YP; Fiolin J; Kusnadi Y; Yulisa ND
    Int Orthop; 2019 Jun; 43(6):1509-1519. PubMed ID: 30747273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic umbilical cord-derived mesenchymal stem cells for treating critical-sized bone defects: a translational study.
    Dilogo IH; Rahmatika D; Pawitan JA; Liem IK; Kurniawati T; Kispa T; Mujadid F
    Eur J Orthop Surg Traumatol; 2021 Feb; 31(2):265-273. PubMed ID: 32804289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell implantation in atrophic nonunion of the long bones: A translational study.
    Ismail HD; Phedy P; Kholinne E; Djaja YP; Kusnadi Y; Merlina M; Yulisa ND
    Bone Joint Res; 2016 Jul; 5(7):287-93. PubMed ID: 27412657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia.
    Dilogo IH; Kamal AF; Gunawan B; Rawung RV
    Int J Surg Case Rep; 2015; 17():106-11. PubMed ID: 26599503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The missing effect of human recombinant Bone Morphogenetic Proteins BMP-2 and BMP-7 in surgical treatment of aseptic forearm nonunion.
    von Rüden C; Morgenstern M; Hierholzer C; Hackl S; Gradinger FL; Woltmann A; Bühren V; Friederichs J
    Injury; 2016 Apr; 47(4):919-24. PubMed ID: 26775208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions.
    Gómez-Barrena E; Padilla-Eguiluz N; Rosset P; Gebhard F; Hernigou P; Baldini N; Rouard H; Sensebé L; Gonzalo-Daganzo RM; Giordano R; García-Rey E; Cordero-Ampuero J; Rubio-Suárez JC; García-Simón MD; Stanovici J; Ehrnthaller C; Huber-Lang M; Flouzat-Lachaniette CH; Chevallier N; Donati DM; Spazzoli B; Ciapetti G; Fleury S; Fernandez MN; Cabrera JR; Avendaño-Solá C; Montemurro T; Panaitescu C; Veronesi E; Rojewski MT; Lotfi R; Dominici M; Schrezenmeier H; Layrolle P
    Injury; 2020 Apr; 51 Suppl 1():S63-S73. PubMed ID: 32139130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17β-estradiol improves the efficacy of exploited autologous bone marrow-derived mesenchymal stem cells in non-union radial defect healing: A rabbit model.
    Zamani Mazdeh D; Mirshokraei P; Emami M; Mirshahi A; Karimi I
    Res Vet Sci; 2018 Jun; 118():11-18. PubMed ID: 29334646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(6):1-57. PubMed ID: 23074475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a long bone fracture non-union healing score after treatment with mesenchymal stromal cells combined to biomaterials.
    Gómez-Barrena E; Padilla-Eguiluz NG; García-Rey E; Hernández-Esteban P; Cordero-Ampuero J; Rubio-Suárez JC;
    Injury; 2020 Apr; 51 Suppl 1():S55-S62. PubMed ID: 32081389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally Manipulative Method for the Expansion of Human Bone Marrow Mesenchymal Stem Cells to Treat Osseous Defects.
    Lawrence LM; Cottrill A; Valluri A; Marenzi G; Denning KL; Valluri J; Claudio PP; Day JB
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
    Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
    Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Secretome, Xenogenic Bone Marrow-Derived Mesenchymal Stem Cells, Bone Morphogenetic Protein-2, Hydroxyapatite Granule and Mechanical Fixation in Critical-Size Defects of Rat Models.
    Dilogo IH; Fiolin J; Canintika AF; Pawitan JA; Luviah E
    Arch Bone Jt Surg; 2022 Jan; 10(1):17-22. PubMed ID: 35291237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions.
    Haubruck P; Tanner MC; Vlachopoulos W; Hagelskamp S; Miska M; Ober J; Fischer C; Schmidmaier G
    Orthop Traumatol Surg Res; 2018 Dec; 104(8):1241-1248. PubMed ID: 30293748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
    Blanco JF; Villarón EM; Pescador D; da Casa C; Gómez V; Redondo AM; López-Villar O; López-Parra M; Muntión S; Sánchez-Guijo F
    Stem Cell Res Ther; 2019 Feb; 10(1):63. PubMed ID: 30795797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study.
    Zhang L; Lai X; Guo Y; Ma J; Fang J; Li G; Xu L; Yin W; Chen Z
    Ren Fail; 2021 Dec; 43(1):1266-1275. PubMed ID: 34493167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose BMP-2 and MSC dual delivery onto coral scaffold for critical-size bone defect regeneration in sheep.
    Decambron A; Fournet A; Bensidhoum M; Manassero M; Sailhan F; Petite H; Logeart-Avramoglou D; Viateau V
    J Orthop Res; 2017 Dec; 35(12):2637-2645. PubMed ID: 28401593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Núñez-Córdoba JM; López-Elío S; Andreu E; Sánchez-Guijo F; Aquerreta JD; Bondía JM; Valentí-Azcárate A; Del Consuelo Del Cañizo M; Villarón EM; Valentí-Nin JR; Prósper F
    J Transl Med; 2018 Jul; 16(1):213. PubMed ID: 30064455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of BMMSC-seeded BMP-6/nHAG/GMS Scaffolds for Bone Regeneration.
    Li X; Zhang R; Tan X; Li B; Liu Y; Wang X
    Int J Med Sci; 2019; 16(7):1007-1017. PubMed ID: 31341414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Masquelet technique using allogeneic umbilical cord-derived mesenchymal stem cells for infected non-union femoral shaft fracture with a 12 cm bone defect: A case report.
    Dilogo IH; Primaputra MRA; Pawitan JA; Liem IK
    Int J Surg Case Rep; 2017; 34():11-16. PubMed ID: 28324799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.